Mann Brenda 4
4 · EYEGATE PHARMACEUTICALS INC · Filed May 6, 2020
Insider Transaction Report
Form 4
Mann Brenda
VP of Research & Development
Transactions
- Tax Payment
Common Stock
2020-05-05$5.10/sh−113$576→ 18,033 total
Footnotes (1)
- [F1]Sale of shares to cover taxes due on restricted stock that vested on 05/01/2020.